Patient satisfaction with medication for gastroesophageal reflux disease: A systematic review

21Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BACKGROUND: Patient satisfaction is increasingly regarded as an important aspect of measuring treatment success in individuals with gastroesophageal reflux disease (GERD). OBJECTIVE: To review how satisfied patients with GERD are with their medication, and to analyze the usefulness of patient satisfaction as a clinical end point by comparing it with symptom improvement. METHODS: Systematic searches of the PubMed and EMBASE databases identified clinical trials and patient surveys published between 1966 and 2009. RESULTS: Twelve trials reported that 56% to 100% of patients were 'satisfied' or 'very satisfied' with proton pump inhibitor (PPI) treatment for GERD. Patient satisfaction levels were higher for PPIs than other GERD medications in two trials. The sample-size-weighted average proportion of patients 'satisfied' with their PPI after four weeks of treatment in trials was 93% (95% CI 87% to 99%), with 73% (95% CI 62% to 83%) being 'very satisfied'. In four surveys, the average proportion of patients 'satisfied' with their PPI treatment was 82% (95% CI 73% to 90%) and 62% (95% CI 48% to 75%) were 'very satisfied'. Seven trials found a positive association between patient satisfaction and symptom improvement, and two surveys between satisfaction and improved health-related quality of life. Three trials found that continuous treatment yielded higher rates of satisfaction than on-demand therapy. CONCLUSIONS: More than one-half of patients were satisfied with their PPI medication in trials, and more patients were satisfied with PPIs than other medication types. An association between patient satisfaction and symptom resolution was found, suggesting that patient satisfaction is a useful end point for evaluating GERD treatment success. ©2012 Pulsus Group Inc. All rights reserved.

References Powered by Scopus

The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus

3207Citations
N/AReaders
Get full text

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis

842Citations
N/AReaders
Get full text

Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring

577Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015

221Citations
N/AReaders
Get full text

Current trends in the management of gastroesophageal reflux disease

139Citations
N/AReaders
Get full text

Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review

48Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Van Zanten, S. V., Henderson, C., & Hughes, N. (2012). Patient satisfaction with medication for gastroesophageal reflux disease: A systematic review. Canadian Journal of Gastroenterology. Pulsus Group Inc. https://doi.org/10.1155/2012/235476

Readers over time

‘12‘13‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

62%

Researcher 9

31%

Professor / Associate Prof. 1

3%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 26

65%

Pharmacology, Toxicology and Pharmaceut... 5

13%

Nursing and Health Professions 5

13%

Psychology 4

10%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0